Approval · Notice of Compliance 18658 · 2016
TIMOPTIC: Notice of Compliance 18658
Issued October 28, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18658
- Date
- October 28, 2016
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIMOPTIC | 00451207 | Marketed |
| TIMOPTIC-XE | 02171880 | Cancelled Post Market |
| TIMOPTIC-XE | 02171899 | Marketed |
Medicinal ingredients
- TIMOLOL MALEATE 0.5 PER
- TIMOLOL MALEATE 0.25 PER